Results 51 to 60 of about 24,763,168 (195)

Insight into the dynamic of gadolinium based contrast agent (GBCA) hypersensitivity: Acquisition, persistence and disappearance. [PDF]

, 2018
Anaphylaxis against gadolinium based contrast agents (GBCAs) has been reported in all severity grades but is less frequent than hypersensitivity/allergy against iodinated contrast materials.
Johannes T. Heverhagen, Ingrid Boehm, Martin Hungerbühler, Böhm, Ingrid, Hungerbuehler, Martin, Heverhagen, Johannes   +5 more
core   +1 more source

Gadolinium Effects on Liposome Fluidity and Size Depend on the Headgroup and Side Chain Structure of Key Mammalian Brain Lipids

Molecules, 2023
The lanthanide metal gadolinium has been used in the healthcare industry as a paramagnetic contrast agent for years. Gadolinium deposition in brain tissue and kidneys has been reported following gadolinium-based contrast agent administration to patients ...
Kianmehr Farzi, Travis Issler, Colin Unruh, Elmar J. Prenner   +3 more
doaj   +1 more source

Superselective intra-arterial infusion of cisplatin and concomitant radiation therapy (RADPLAT) using gadolinium-based contrast agent in a patient with severe iodine allergy: A case report

Radiology Case Reports
Maxillary sinus squamous cell carcinoma (MS-SCC) is a rare malignancy that is often diagnosed at an advanced stage. We report a case of locally advanced MS-SCC that was successfully treated with super-selective intra-arterial cisplatin infusion ...
Yume Sanji, MD, Mizuki Ozawa, MD, Seiya Mochizuki, Yuko Kubo, MD, Madoka Sakuramachi, MD, Hideaki Takahashi, MD, Akane Yoshiba, MD, Go Omura, MD, Miyuki Sone, MD   +8 more
doaj   +1 more source

Visible T1-hyperintensity of the dentate nucleus after multiple administrations of macrocyclic gadolinium-based contrast agents: yes or no?

Insights into Imaging, 2019
Objectives To investigate the appearance of visible dentate nucleus (DN) T1-hyperintensity and quantify changes in DN/pons (DN/P) signal intensity (SI) ratio in MS patients after the exclusive administration of macrocyclic GBCAs.
Alessandra Splendiani, Antonella Corridore, Silvia Torlone, Milvia Martino, Antonio Barile, Ernesto Di Cesare, Carlo Masciocchi   +6 more
doaj   +1 more source

Uptake of Gadolinium-Based Contrast Agents by Blood Cells During Contrast-Enhanced MRI Examination. [PDF]

OBJECTIVES Gadolinium-based contrast agents (GBCAs) are routinely used in magnetic resonance imaging (MRI) examinations. However, there is limited knowledge about the interaction with and distribution of the drug in human cells. This lack of knowledge
Broekmann, Peter, von Tengg-Kobligk, Hendrik, Hofmann, Lukas, Heverhagen, Johannes Thomas, Kempf, Christoph, Parakkattel, Dixy, Ruprecht, Nico, Lüdi, Nicola   +7 more
core   +2 more sources

Reducing contrast agent residuals in hospital wastewater: the GREENWATER study protocol

European Radiology Experimental, 2023
The potential enviromental impact of iodinated (ICAs) and gadolinium-based contrast agents (GBCAs) have recently come under scrutiny, considering the current nonselective wastewater treatment.
Moreno Zanardo, Andrea Cozzi, Rosanna Cardani, Laura Valentina Renna, Francesco Pomati, Luigi Asmundo, Giovanni Di Leo, Francesco Sardanelli   +7 more
doaj   +1 more source

Theranostics and contrast agents for magnetic resonance imaging

Biomaterials Research, 2018
Background Magnetic resonance imaging is one of the diagnostic tools that uses magnetic particles as contrast agents. It is noninvasive methodology which provides excellent spatial resolution. Although magnetic resonance imaging offers great temporal and
Yohan Jeong, Hee Sook Hwang, Kun Na
doaj   +1 more source

Gadolinium deposition in the brain of dogs after multiple intravenous administrations of linear gadolinium based contrast agents.

PLoS ONE, 2020
OBJECTIVE:To determine the effect of a linear gadolinium-based contrast agent (GBCA) on the signal intensity (SI) of the deep cerebellar nuclei (DCN) in a retrospective clinical study on dogs after multiple magnetic resonance (MR) examinations with ...
Henning Richter, Patrick Bücker, Calvin Dunker, Uwe Karst, Patrick Robert Kircher   +4 more
doaj   +1 more source

Chemistry of tumour targeted T1 based MRI contrast agents

, 2010
For effective tumour imaging by magnetic resonance imaging (MRI) there is a clear need to develop organ, tissue and cell specific contrast agents that can selectively bind to tumour biomarkers.
Kamaly, N., Bell, J.D., Miller, A.D.
core   +1 more source

Dendrimer-based Macromolecular MRI Contrast Agents: Characteristics and Application

Molecular Imaging, 2003
Numerous macromolecular MRI contrast agents prepared employing relatively simple chemistry may be readily available that can provide sufficient enhancement for multiple applications.
Hisataka Kobayashi, Martin W. Brechbiel
doaj   +1 more source